The American Journal of Medicine
Volume 116, Issue 3 , Pages 151-157, 1 February 2004

Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking☆

  • Dorothy K Hatsukami, PhD

      Affiliations

    • Department of Psychiatry (DKH, MK), University of Minnesota at Twin Cities, Minneapolis, Minnesota, USA
    • Corresponding Author InformationRequests for reprints should be addressed to Dorothy K. Hatsukami, PhD, University of Minnesota, Tobacco Use Research Center, 2701 University Avenue, Suite 201, Minneapolis, Minnesota 55414, USA
    • ,
  • Stephen Rennard, MD

      Affiliations

    • University of Nebraska Medical Center (SR), Omaha, Nebraska, USA
    • ,
  • Manoj K Patel, PharmD

      Affiliations

    • GlaxoSmithKline (MKP, MK, GD, BDJ), Research Triangle Park, North Carolina, USA
    • ,
  • Michael Kotlyar, PharmD

      Affiliations

    • Department of Psychiatry (DKH, MK), University of Minnesota at Twin Cities, Minneapolis, Minnesota, USA
    • Department of Experimental and Clinical Pharmacology, College of Pharmacy (MK), University of Minnesota at Twin Cities, Minneapolis, Minnesota, USA
    • GlaxoSmithKline (MKP, MK, GD, BDJ), Research Triangle Park, North Carolina, USA
    • ,
  • Robert Malcolm, MD

      Affiliations

    • Institute of Psychiatry (RM), Medical University of South Carolina, Charleston, South Carolina, USA
    • ,
  • Mitchell A Nides, PhD

      Affiliations

    • Los Angeles Clinical Trials (MAN), Los Angeles, California, USA
    • ,
  • Greg Dozier, MPH

      Affiliations

    • GlaxoSmithKline (MKP, MK, GD, BDJ), Research Triangle Park, North Carolina, USA
    • ,
  • Matthew P Bars, MS

      Affiliations

    • Smoking Consultation Service (MPB), Fort Lee, New Jersey, USA
    • ,
  • Brenda D Jamerson, PharmD

      Affiliations

    • GlaxoSmithKline (MKP, MK, GD, BDJ), Research Triangle Park, North Carolina, USA
    • Campbell University Department of Pharmaceutical Sciences, Clinical Research (BDJ), Durham, North Carolina, USA

Received 26 June 2002; accepted 25 July 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This study was supported by GlaxoSmithKline, Research Triangle Park, North Carolina. The sponsor was responsible for finalizing the design of the study and oversight of the research project, had primary responsibility for conducting the data analyses, and reviewed the final paper.

PII: S0002-9343(03)00655-7

doi:10.1016/j.amjmed.2003.07.018

The American Journal of Medicine
Volume 116, Issue 3 , Pages 151-157, 1 February 2004

Article Tools

* Image Usage & Resolution